Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 427-434

  Woody, Neil M ^a   Videtic, Gregory M M ^a   Stephans, Kevin L ^a   Djemil, Toufik ^a   Kim, Yongbok ^b   Xia, Ping ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Chest wall pain; Modified effective uniform dose; Radiobiologic effect; Stage I lung cancer; Stereotactic body radiation therapy

Indexed keywords

CHEST WALL; LUNG CANCER; MODIFIED EFFECTIVE UNIFORM DOSE; RADIOBIOLOGIC EFFECT; STEREOTACTIC BODY RADIATION THERAPY;

BIOLOGICAL ORGANS; FRACTIONATION; LOGISTICS; RADIOTHERAPY; UNCERTAINTY ANALYSIS;

HEALTH;

ADULT; AGED; ARTICLE; BODY MASS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SENSITIVITY AND SPECIFICITY; STEREOTACTIC BODY RADIATION THERAPY; THORAX PAIN; THORAX WALL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEST PAIN; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIATION INJURIES; RADIOBIOLOGY; RADIOSURGERY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; THORACIC WALL; TIME FACTORS;

EID: 84859857119     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.06.1971     Document Type: Article

References (19)

1. G.S. Sibley Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma: Smaller volumes and higher doses - a review Cancer 82 1998 433 438
2. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer: Lung cancer study group Ann Thorac Surg 60 1995 615 622 discussion 622-623
3. G.M. Videtic, K. Stephans, and C. Reddy Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: Excellent local control Int J Radiat Oncol Biol Phys 77 2010 344 349
4. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
5. K.E. Rusthoven, B.D. Kavanagh, and S.H. Burri Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases J Clin Oncol 27 2009 1579 1584
6. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
7. J. Nyman, K.A. Johansson, and U. Hulten Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer: Mature results for medically inoperable patients Lung Cancer 51 2006 97 103
8. N. Pettersson, J. Nyman, and K.A. Johansson Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: A dose- and volume-response analysis Radiother Oncol 91 2009 360 368
9. B.S. Hoppe, B. Laser, and A.V. Kowalski Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: Who's at risk? Int J Radiat Oncol Biol Phys 72 2008 1283 1286
10. N.E. Dunlap, J. Cai, and G.B. Biedermann Chest wall volume receiving >30 gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 76 2010 796 801
11. K.L. Stephans, T. Djemil, and C.A. Reddy A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: The Cleveland Clinic experience J Thorac Oncol 4 2009 976 982
12. C.S. Park, Y. Kim, and N. Lee Method to account for dose fractionation in analysis of IMRT plans: Modified equivalent uniform dose Int J Radiat Oncol Biol Phys 62 2005 925 932
13. N.P. Nguyen, L. Garland, and J. Welsh Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma Cancer Treat Rev 34 2008 719 727
14. G.M. Videtic, and K.L. Stephans The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: An emerging standard for the medically inoperable patient? Curr Oncol Rep 17 2010 235 241
15. M.E. Charlson, P. Pompei, and K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chronic Dis 40 1987 373 383
16. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
17. J.P. Voroney, A. Hope, and M.R. Dahele Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer J Thorac Oncol 4 2009 1035 1037
18. C. Park, L. Papiez, and S. Zhang Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy Int J Radiat Oncol Biol Phys 70 2008 847 852
19. J. Welsh, J. Thomas, and D. Shah Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 81 2011 91 96